Novel polymorphic forms of (4-{[(5-{[ (3-chlorophenyl)methyl]oxy}-2-methylph enyl) carbonyl]amino}-3-methylphenyl)acetic acid

Details for Australian Patent Application No. 2009256689 (hide)

Owner Glaxo Group Limited

Inventors Vallance, Sarah

Agent Davies Collison Cave

Pub. Number AU-A-2009256689

PCT Pub. Number WO2009/150119

Priority 0810617.1 10.06.08 GB

Filing date 8 June 2009

Wipo publication date 17 December 2009

International Classifications

C07C 235/56 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

Event Publications

16 December 2010 PCT application entered the National Phase

  PCT publication WO2009/150119 Priority application(s): WO2009/150119

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009256694-Group of pots for food products

2009256688-Novel salts of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2methylphenyl)carbonyl]amino}-3-methylphenyl )acetic acid